SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KSF REMINDS BMY, EAR, HMLP, SAM INVESTORS of Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
First And Only Randomized, Double-blind, Head-to-head Study Comparing Aimovig® , An Anti-CGRP Pathway Therapy, To Topiramate Published In Cephalalgia Market News
Allergan, an AbbVie Company, to Present New Data from its Leading Eye Care Portfolio at the AAO 2021 Annual Meeting Pharmaceutical Investing
Neoadjuvant Opdivo Plus Chemotherapy Significantly Improves Event-Free Survival in Patients with Resectable Non-Small Cell Lung Cancer in Phase 3 CheckMate -816 Trial Pharmaceutical Investing
Bristol Myers Squibb to Present Data Across Robust Cardiovascular Portfolio at American Heart Association Scientific Sessions 2021 Pharmaceutical Investing
BMY, HEPS, HMLP INVESTOR ALERT BY CLAIMSFILER: Pending Lead Plaintiff Deadline in Class Action Lawsuits Pharmaceutical Investing
AbbVie Presents Integrated Efficacy and Safety Data From Two Phase 3 Trials on Risankizumab in Psoriatic Arthritis at ACR Convergence 2021 Pharmaceutical Investing
BriaCell Adds Pioneering Immunologist and Cancer Immunotherapy Expert, Suzanne Ostrand-Rosenberg, Ph.D., to its Scientific Advisory Board Life Science Investing
